Skip to main content
. 2022 Sep 5;16(6):921–929. doi: 10.5009/gnl210488

Table 4.

Location and Behavior of CD and Extent of UC at Diagnosis

Variable CD UC p-value
Esophagogastroduodenoscopy
Esophagus 19 (8.4) 2 (2.5) 0.126
Stomach 83 (36.6) 10 (12.5) <0.001
Duodenum 47 (20.7) 6 (7.5) 0.012
Non-caseating granuloma 5 (2.2) - NA
Small bowel and perianal evaluation
Duodenum 3 (1.3) 0 0.710
Jejunum 31 (13.7) 2 (2.5) 0.010
Proximal ileum 33 (14.5) 1 (1.2) 0.002
Distal ileum 84 (37.0) 2 (2.5) <0.001
Terminal ileum 151 (66.5) 8 (10.0) <0.001
Perianal fistula/abscess 87 (38.3) 0 <0.001
Colonoscopy
Terminal ileum 141 (62.1) 13 (16.2) <0.001
Caecum 138 (60.8) 39 (48.8) 0.081
Ascending colon 139 (61.2) 43 (53.8) 0.299
Transverse colon 135 (59.5) 46 (57.5) 0.860
Descending colon 130 (57.3) 50 (62.5) 0.493
Sigmoid colon 135 (59.5) 52 (65.0) 0.460
Rectum 119 (52.4) 67 (83.8) <0.001
Non-caseating granuloma 88 (38.8) - NA
Endoscopic scores
SES-CD 20 (9–27) - NA
Mayo endoscopic score - 2 (2–3) NA

Data are presented as number (%) or median (interquartile range).

CD, Crohn’s disease; UC, ulcerative colitis; SES-CD, simple endoscopic score for CD; NA, not applicable.